{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T14:32:10Z","timestamp":1764858730587},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1093\/jjco\/hyu035","type":"journal-article","created":{"date-parts":[[2014,4,10]],"date-time":"2014-04-10T03:38:40Z","timestamp":1397101120000},"page":"597-601","source":"Crossref","is-referenced-by-count":2,"title":["Serous Tubal Intraepithelial Carcinoma in a Japanese Woman with a Deleterious BRCA1 Mutation"],"prefix":"10.1093","volume":"44","author":[{"given":"Hiroshi","family":"Ishikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takako","family":"Kiyokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emi","family":"Utsuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyuki","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumio","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makio","family":"Shozu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,4,9]]},"reference":[{"key":"key\n\t\t\t\t20170511082026_HYU035C1","article-title":"Issues of concern in risk assessment, genetic counseling, and genetic testing of younger breast cancer patients in Japan","author":"Bando","year":"2013","journal-title":"Breast Cancer"},{"key":"key\n\t\t\t\t20170511082026_HYU035C2","article-title":"Development of an integrated support system for hereditary cancer and its impact on gynecologic services","author":"Morii-Kashima","year":"2013","journal-title":"Int J Clin Oncol"},{"key":"key\n\t\t\t\t20170511082026_HYU035C3","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ogc.2013.05.009","article-title":"Hereditary breast\/ovarian cancer syndrome: a primer for obstetricians\/gynecologists","volume":"40","author":"Meaney-Delman","year":"2013","journal-title":"Obstet Gynecol Clin North Am"},{"key":"key\n\t\t\t\t20170511082026_HYU035C4","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/jnci\/94.18.1365","article-title":"Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program","volume":"94","author":"Brose","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20170511082026_HYU035C5","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170511082026_HYU035C6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11864-012-0215-3","article-title":"Management of genetic syndromes predisposing to gynecologic cancers","volume":"14","author":"Miesfeldt","year":"2013","journal-title":"Curr Treat Options Oncol"},{"key":"key\n\t\t\t\t20170511082026_HYU035C7","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/AOG.0b013e3181a106d4","article-title":"Hereditary breast and ovarian cancer syndrome","volume":"113","author":"ACOG Practice Bulletin No. 103","year":"2009","journal-title":"Obstet Gynecol"},{"key":"key\n\t\t\t\t20170511082026_HYU035C8","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1097\/IGC.0b013e3182a80ac8","article-title":"Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC)","volume":"23","author":"Wethington","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"key\n\t\t\t\t20170511082026_HYU035C9","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1200\/JCO.2008.16.4814","article-title":"Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention","volume":"26","author":"Carlson","year":"2008","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20170511082026_HYU035C10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J Pathol"},{"key":"key\n\t\t\t\t20170511082026_HYU035C11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejca.2012.07.021","article-title":"Support of the \u2018fallopian tube hypothesis\u2019 in a prospective series of risk-reducing salpingo-oophorectomy specimens","volume":"49","author":"Reitsma","year":"2013","journal-title":"Eur J Cancer"},{"key":"key\n\t\t\t\t20170511082026_HYU035C12","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1471-0528.2011.02920.x","article-title":"Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status","volume":"118","author":"Manchanda","year":"2011","journal-title":"BJOG"},{"key":"key\n\t\t\t\t20170511082026_HYU035C13","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.ajog.2006.03.006","article-title":"Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy","volume":"194","author":"Lamb","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"key\n\t\t\t\t20170511082026_HYU035C14","article-title":"Prevalence and differentiation of hereditary breast and ovarian cancers in Japan","author":"Nakamura","year":"2013","journal-title":"Breast Cancer"},{"key":"key\n\t\t\t\t20170511082026_HYU035C15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/jjco\/hyt171","article-title":"Family history and BRCA1\/BRCA2 status among Japanese ovarian cancer patients and occult cancer in a BRCA1 mutant case","volume":"44","author":"Hirasawa","year":"2014","journal-title":"Jpn J Clin Oncol"},{"key":"key\n\t\t\t\t20170511082026_HYU035C16","doi-asserted-by":"crossref","first-page":"10096","DOI":"10.1158\/0008-5472.CAN-05-1241","article-title":"Application of embryonic lethal or other obvious phenotypes to characterize the clinical significance of genetic variants found in trans with known deleterious mutations","volume":"65","author":"Judkins","year":"2005","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170511082026_HYU035C17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/his.12046","article-title":"Fallopian tube precursors of ovarian low- and high-grade serous neoplasms","volume":"62","author":"Vang","year":"2013","journal-title":"Histopathology"},{"key":"key\n\t\t\t\t20170511082026_HYU035C18","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00428-010-0979-4","article-title":"Mucosal carcinoma of the fallopian tube coexists with ovarian cancer of serous subtype only: a study of Japanese cases","volume":"457","author":"Maeda","year":"2010","journal-title":"Virchows Arch"},{"key":"key\n\t\t\t\t20170511082026_HYU035C19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10689-008-9208-6","article-title":"Use of total abdominal hysterectomy and hormone replacement therapy in BRCA1 and BRCA2 mutation carriers undergoing risk-reducing salpingo-oophorectomy","volume":"8","author":"Gabriel","year":"2009","journal-title":"Fam Cancer"},{"key":"key\n\t\t\t\t20170511082026_HYU035C20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20170511082026_HYU035C21","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/jjco\/hyt036","article-title":"Experience of risk-reducing salpingo-oophorectomy for a BRCA1 mutation carrier and establishment of a system performing a preventive surgery for hereditary breast and ovarian cancer syndrome in Japan: our challenges for the future","volume":"43","author":"Hirasawa","year":"2013","journal-title":"Jpn J Clin Oncol"},{"key":"key\n\t\t\t\t20170511082026_HYU035C22","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jjco\/article\/44\/6\/597\/827197\/Serous-Tubal-Intraepithelial-Carcinoma-in-a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T11:18:56Z","timestamp":1498130336000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article-lookup\/doi\/10.1093\/jjco\/hyu035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,9]]},"references-count":22,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,4,9]]},"published-print":{"date-parts":[[2014,6]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyu035","relation":{},"ISSN":["1465-3621","0368-2811"],"issn-type":[{"value":"1465-3621","type":"electronic"},{"value":"0368-2811","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4,9]]}}}